RNA Nanotherapeutics Inhibit the Propagation of Neurotoxic Astroglial Responses Following Brain Injuries

Research from the Department of Clinical Neurosciences and Stem Cell Institute at Cambridge University demonstrates that RNA nanotherapeutics curtail the production of an inflammation-spreading signal released by cells of the central nervous system (CNS) in response to injury or disease.